Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Home / Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)

Estimated reading time: < 1 min

Condition

Peritoneal Mesotheliomas

Estimated Enrollment: 19

Age Group: Child, Adult, Senior

Gender: All

Study Type: Observational

Study Design Allocation: Observational Model: Case-Crossover|Time Perspective: Retrospective

Study ID Numbers: Maisonneuve Rosemont Hospital|12112

Study First Received: March 12, 2013

Last Updated: March 15, 2013

Estimated Primary Completion Date: March 2013

 

Primary Outcome Measures:

Overall survival|Disease-Free survival

Sponsors and Collaborators:

Maisonneuve-Rosemont Hospital

Website Link: https://ClinicalTrials.gov/show/NCT01812148

Was this article helpful?
Dislike 0
Views: 11